Stephen P. Squinto, EVP, Chief Global Operations Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 7,055 shares at $155.55 ($1.1M) on 2014-02-07, disclosed to the SEC on 2014-02-10.
Seasonal sale ($1.1M) by EVP, Chief Global Operations Officer — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.11 | 3,800 | $589K | 52.9% |
| 2 | $155.55 | 1,600 | $249K | 22.3% |
| 3 | $157.51 | 20 | $3K | 0.3% |
| 4 | $167.31 | 1,635 | $274K | 24.5% |
| Total | $158.04 avg | 7,055 | $1.1M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |